Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Aug 04, 2022 9:25am
120 Views
Post# 34870687

RE:AGM reflected huge retail distribution & lack of "caring"

RE:AGM reflected huge retail distribution & lack of "caring"DD, have you come across an accurate list of the number of retail vs institutional holders of Labs?

With all the manipulation here the last couple years, it would appear there is a large group churning shares up and down profitting on a few cent swing each week.

With approx 7 million shares still short, we need to generate interest from the likes of the Reddit army to get the shorts running for cover, and it wont take long for balance to restore itself  lol


What are your thoughts on any benefits to extending the date of the 2021 Warrants expiry or reducing the exersize price as another source of funding for the treasury.

As much as I would love to see it, hitting .70 cents by March 2023 might be a bit of a reach and those who participated in that  March 2021 bought deal financing are down substantially from the .58 cent shares they purchased and they represent a large shareholding at almost 58 million shares.



<< Previous
Bullboard Posts
Next >>